Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities

Hisafumi Matsuoka*, Hans Fors, Ingvar Bosaeus, Sten Rosberg, Kerstin Albertsson-Wikland, Ragnar Bjarnason

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Objective: The aim of this study was to follow changes in body composition, estimated by dual-energy X-ray absorptiometry (DXA), in relation to changes in leptin during the first year of GH therapy in order to test the hypothesis that leptin is a metabolic signal involved in the regulation of GH secretion in children. Design and Methods: In total, 33 prepubertal children were investigated. Their mean (S.D.) chronological age at the start of GH treatment was 11.5 (1.6) years, and their mean height was -2.33 (0.38) S.D. scores (SDS). GH was administered subcutaneously at a daily dose of 0.1 (n = 26) or 0.2 (n = 7) IU/kg body weight. Ten children were in the Swedish National Registry for children with GH deficiency, and twenty-three children were involved in trials of GH treatment for idiopathic short stature. Spontaneous 24-h GH secretion was studied in 32 of the children. In the 24-h GH profiles, the maximum level of GH was determined and the secretion rate estimated by deconvolution analysis (GH(t)). Serum leptin levels were measured at the start of GH treatment and after 10 and 30 days and 3, 6 and 12 months of treatment. Body composition measurements, by DXA, were performed at baseline and 12 months after the onset of GH treatment. Results: After 12 months of GH treatment, mean height increased from -2.33 to -1.73 SDS and total body fat decreased significantly by 3.0 (3.3)%. Serum leptin levels were decreased significantly at all time points studied compared with baseline. There was a significant correlation between the change in total body fat and the change in serum leptin levels during the 12 months of GH treatment, whereas the leptin concentration per unit fat mass did not change. In a multiple stepwise linear regression analysis with 12 month change in leptin levels as the dependent variable, the percentage change in fat over 12 months, the baseline fat mass (%) of body mass and GH(t) accounted for 24.0%, 11.5% and 12.2% of the variability respectively. Conclusions: There are significant correlations between changes in leptin and fat and endogenous GH secretion in short children with various GH secretory capacities. Leptin may be the messenger by which the adipose tissue affects hypothalamic regulation of GH secretion.

Original languageEnglish
Pages (from-to)35-42
Number of pages8
JournalEuropean Journal of Endocrinology
Volume140
Issue number1
DOIs
Publication statusPublished - Jan 1999

Fingerprint

Dive into the research topics of 'Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities'. Together they form a unique fingerprint.

Cite this